{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:22:17Z","timestamp":1793935337247,"version":"4.8.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11886-025-02195-x","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T04:18:17Z","timestamp":1737951497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Contemporary Insights into LMNA Cardiomyopathy"],"prefix":"10.1007","volume":"27","author":[{"given":"Iswaree D.","family":"Balakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal K.","family":"Lakdawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"2195_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2020.00761","volume":"11","author":"S Crasto","year":"2020","unstructured":"Crasto S, My I, Di Pasquale E. The broad spectrum of LMNA cardiac diseases: from molecular mechanisms to clinical phenotype. Front Physiol. 2020;11:1\u201311. https:\/\/doi.org\/10.3389\/fphys.2020.00761.","journal-title":"Front Physiol"},{"key":"2195_CR2","doi-asserted-by":"publisher","unstructured":"Storey EC, Fuller HR. Genotype-phenotype correlations in human diseases caused by mutations of LINC complex-associated genes: a systematic review and meta-summary. Cells. 2022;11. https:\/\/doi.org\/10.3390\/cells11244065.","DOI":"10.3390\/cells11244065"},{"key":"2195_CR3","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","volume":"341","author":"D Fatkin","year":"1999","unstructured":"Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med. 1999;341:1715\u201324.","journal-title":"N Engl J Med"},{"key":"2195_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1161\/CIRCULATIONAHA.121.058143","volume":"146","author":"RA Shah","year":"2022","unstructured":"Shah RA, Asatryan B, Sharaf Dabbagh G, et al. Frequency, penetrance, and variable expressivity of dilated cardiomyopathy-associated putative pathogenic gene variants in UK biobank participants. Circulation. 2022;146:110\u201324. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.058143.","journal-title":"Circulation"},{"key":"2195_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2022.823717","volume":"9","author":"GDA Pessente","year":"2022","unstructured":"Pessente GDA, Sacilotto L, Calil ZO, et al. Effect of occurrence of lamin A\/C (LMNA) genetic variants in a cohort of 101 consecutive apparent \u201cLone AF\u201d patients: results and insights. Front Cardiovasc Med. 2022;9:1\u20139. https:\/\/doi.org\/10.3389\/fcvm.2022.823717.","journal-title":"Front Cardiovasc Med"},{"key":"2195_CR6","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","volume":"402","author":"S Heymans","year":"2023","unstructured":"Heymans S, Lakdawala NK, Tsch\u00f6pe C, Klingel K. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches. Lancet. 2023;402:998\u20131011. https:\/\/doi.org\/10.1016\/S0140-6736(23)01241-2.","journal-title":"Lancet"},{"key":"2195_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.4070\/KCJ.2021.0154","volume":"51","author":"KH Kim","year":"2021","unstructured":"Kim KH, Pereira NL. Genetics of cardiomyopathy: clinical and mechanistic implications for heart failure. Korean Circ J. 2021;51:797\u2013836. https:\/\/doi.org\/10.4070\/KCJ.2021.0154.","journal-title":"Korean Circ J"},{"key":"2195_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0735-1097(02)01724-2","volume":"39","author":"E Arbustini","year":"2002","unstructured":"Arbustini E, Pilotto A, Repetto A, et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A\/C defect-related disease. J Am Coll Cardiol. 2002;39:981\u201390. https:\/\/doi.org\/10.1016\/S0735-1097(02)01724-2.","journal-title":"J Am Coll Cardiol"},{"key":"2195_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/CIRCGENETICS.116.001603","volume":"10","author":"S Nishiuchi","year":"2017","unstructured":"Nishiuchi S, Makiyama T, Aiba T, et al. Gene-based risk stratification for cardiac disorders in LMNA mutation carriers. Circ Cardiovasc Genet. 2017;10:5\u20137. https:\/\/doi.org\/10.1161\/CIRCGENETICS.116.001603.","journal-title":"Circ Cardiovasc Genet"},{"key":"2195_CR10","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1093\/eurheartj\/ehab286","volume":"42","author":"U Tayal","year":"2021","unstructured":"Tayal U, Ware JS, Lakdawala NK, et al. Understanding the genetics of adult-onset dilated cardiomyopathy: what a clinician needs to know. Eur Heart J. 2021;42:2384\u201396. https:\/\/doi.org\/10.1093\/eurheartj\/ehab286.","journal-title":"Eur Heart J"},{"key":"2195_CR11","doi-asserted-by":"publisher","unstructured":"Cesar S, Campuzano O, Cruzalegui J, et al. Characterization of cardiac involvement in children with LMNA-related muscular dystrophy. Front Cell Dev Biol. 2023;11. https:\/\/doi.org\/10.3389\/fcell.2023.1142937.","DOI":"10.3389\/fcell.2023.1142937"},{"key":"2195_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","volume":"140","author":"K Wahbi","year":"2019","unstructured":"Wahbi K, Ben Yaou R, Gandjbakhch E, et al. Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies. Circulation. 2019;140:293\u2013302. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.039410.","journal-title":"Circulation"},{"key":"2195_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/openhrt-2016-000474","volume":"4","author":"L Ollila","year":"2017","unstructured":"Ollila L, Nikus K, Holmstr\u00f6m M, et al. Clinical disease presentation and ECG characteristics of LMNA mutation carriers. Open Hear. 2017;4:1\u20139. https:\/\/doi.org\/10.1136\/openhrt-2016-000474.","journal-title":"Open Hear"},{"key":"2195_CR14","doi-asserted-by":"publisher","unstructured":"Castrini AI, Skj\u00f8lsvik E, Estensen ME, et al. Pregnancy and progression of cardiomyopathy in women with LMNA genotype-positive. J Am Heart Assoc. 2022;11. https:\/\/doi.org\/10.1161\/JAHA.121.024960.","DOI":"10.1161\/JAHA.121.024960"},{"key":"2195_CR15","doi-asserted-by":"publisher","unstructured":"Vahabikashi A, Adam SA, Medalia O, Goldman RD. Nuclear lamins: structure and function in mechanobiology. APL Bioeng. 2022;6. https:\/\/doi.org\/10.1063\/5.0082656.","DOI":"10.1063\/5.0082656"},{"key":"2195_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/19491034.2018.1489195","volume":"9","author":"G Peretto","year":"2018","unstructured":"Peretto G, Sala S, Benedetti S, et al. Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease. Nucleus. 2018;9:380\u201391. https:\/\/doi.org\/10.1080\/19491034.2018.1489195.","journal-title":"Nucleus"},{"key":"2195_CR17","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.stem.2020.12.016","volume":"28","author":"PP Shah","year":"2021","unstructured":"Shah PP, Lv W, Rhoades JH, et al. Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes. Cell Stem Cell. 2021;28:938-954.e9. https:\/\/doi.org\/10.1016\/j.stem.2020.12.016.","journal-title":"Cell Stem Cell"},{"key":"2195_CR18","doi-asserted-by":"publisher","unstructured":"Khanamiri S, Moonen J, Wnorowski A, et al. Lovastatin improves endothelial dysfunction and cellular crosstalk in LMNA-related dilated cardiomyopathy. Sci Transl Med. 2020;12. https:\/\/doi.org\/10.1126\/scitranslmed.aax9276.Lovastatin.","DOI":"10.1126\/scitranslmed.aax9276.Lovastatin"},{"key":"2195_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-024-01546-5","volume":"22","author":"RJA Veltrop","year":"2024","unstructured":"Veltrop RJA, Kukk MM, Topouzidou K, et al. From gene to mechanics: a comprehensive insight into the mechanobiology of LMNA mutations in cardiomyopathy. Cell Commun Signal. 2024;22:1\u201317. https:\/\/doi.org\/10.1186\/s12964-024-01546-5.","journal-title":"Cell Commun Signal"},{"key":"2195_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-24849-4","volume":"12","author":"RJ Chai","year":"2021","unstructured":"Chai RJ, Werner H, Li PY, et al. Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathy. Nat Commun. 2021;12:1\u201316. https:\/\/doi.org\/10.1038\/s41467-021-24849-4.","journal-title":"Nat Commun"},{"key":"2195_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1540-8167.2004.40096.x","volume":"16","author":"J Otomo","year":"2005","unstructured":"Otomo J, Kure S, Shiba T, et al. Electrophysiological and histopathological characteristics of progressive atrioventricular block accompanied by familial dilated cardiomyopathy caused by a novel mutation of lamin A\/C gene. J Cardiovasc Electrophysiol. 2005;16:137\u201345. https:\/\/doi.org\/10.1046\/j.1540-8167.2004.40096.x.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2195_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-09929-w","volume":"10","author":"N Salvarani","year":"2019","unstructured":"Salvarani N, Crasto S, Miragoli M, et al. The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy. Nat Commun. 2019;10:1\u201316. https:\/\/doi.org\/10.1038\/s41467-019-09929-w.","journal-title":"Nat Commun"},{"key":"2195_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jjcc.2019.03.019","volume":"74","author":"Y Hasebe","year":"2019","unstructured":"Hasebe Y, Fukuda K, Nakano M, et al. Characteristics of ventricular tachycardia and long-term treatment outcome in patients with dilated cardiomyopathy complicated by lamin A\/C gene mutations. J Cardiol. 2019;74:451\u20139. https:\/\/doi.org\/10.1016\/j.jjcc.2019.03.019.","journal-title":"J Cardiol"},{"key":"2195_CR24","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.hrthm.2021.03.040","volume":"18","author":"R Chauvel","year":"2021","unstructured":"Chauvel R, Derval N, Duchateau J, et al. Persistent atrial fibrillation ablation in cardiac laminopathy: electrophysiological findings and clinical outcomes. Hear Rhythm. 2021;18:1115\u201321. https:\/\/doi.org\/10.1016\/j.hrthm.2021.03.040.","journal-title":"Hear Rhythm"},{"key":"2195_CR25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.hrthm.2021.11.022","volume":"19","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Lin Y, Zhang Y, et al. Familial atrial myopathy in a large multigenerational heart-hand syndrome pedigree carrying an LMNA missense variant in rod 2B domain (p. R335W). Hear Rhythm. 2022;19:466\u201375. https:\/\/doi.org\/10.1016\/j.hrthm.2021.11.022.","journal-title":"Hear Rhythm"},{"key":"2195_CR26","doi-asserted-by":"publisher","first-page":"S202","DOI":"10.1016\/j.hrthm.2023.03.603","volume":"20","author":"W Janes","year":"2023","unstructured":"Janes W, Owais A, Chen H, et al. Po-01-108 elucidating the mechanism of atrial fibrillation in lamin a\/C heart disease using human ipsc-derived atrial cardiomyocytes. Hear Rhythm. 2023;20:S202. https:\/\/doi.org\/10.1016\/j.hrthm.2023.03.603.","journal-title":"Hear Rhythm"},{"key":"2195_CR27","doi-asserted-by":"publisher","first-page":"E003480","DOI":"10.1161\/CIRCGEN.121.003480","volume":"16","author":"M Tremblay-Gravel","year":"2023","unstructured":"Tremblay-Gravel M, Ichimura K, Picard K, et al. Intrinsic atrial myopathy precedes left ventricular dysfunction and predicts atrial fibrillation in lamin A\/C cardiomyopathy. Circ Genomic Precis Med. 2023;16:E003480. https:\/\/doi.org\/10.1161\/CIRCGEN.121.003480.","journal-title":"Circ Genomic Precis Med"},{"key":"2195_CR28","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European society of cardiology (ESC). Eur Heart J. 2023;44:3503\u2013626. https:\/\/doi.org\/10.1093\/eurheartj\/ehad194.","journal-title":"Eur Heart J"},{"key":"2195_CR29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/ehjci\/jeab057","volume":"23","author":"ET Skj\u00f8lsvik","year":"2022","unstructured":"Skj\u00f8lsvik ET, Haugen Lie \u00d8, Chivulescu M, et al. Progression of cardiac disease in patients with lamin A\/C mutations. Eur Heart J Cardiovasc Imaging. 2022;23:543\u201350. https:\/\/doi.org\/10.1093\/ehjci\/jeab057.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2195_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","volume":"59","author":"IAW Van Rijsingen","year":"2012","unstructured":"Van Rijsingen IAW, Arbustini E, Elliott PM, et al. Risk factors for malignant ventricular arrhythmias in Lamin A\/C mutation carriers: a European cohort study. J Am Coll Cardiol. 2012;59:493\u2013500. https:\/\/doi.org\/10.1016\/j.jacc.2011.08.078.","journal-title":"J Am Coll Cardiol"},{"key":"2195_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.hrcr.2020.03.008","volume":"6","author":"AL Cirino","year":"2020","unstructured":"Cirino AL, Cuddy S, Lakdawala NK. Deletion of entire LMNA gene as a cause of cardiomyopathy. Hear Case Rep. 2020;6:395\u20137. https:\/\/doi.org\/10.1016\/j.hrcr.2020.03.008.","journal-title":"Hear Case Rep"},{"key":"2195_CR32","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/ejhf.1241","volume":"20","author":"RA Al-Saaidi","year":"2018","unstructured":"Al-Saaidi RA, Rasmussen TB, Birkler RID, et al. The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelope. Eur J Heart Fail. 2018;20:1404\u201312. https:\/\/doi.org\/10.1002\/ejhf.1241.","journal-title":"Eur J Heart Fail"},{"key":"2195_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/CIRCGENETICS.117.001816","volume":"10","author":"E Arbustini","year":"2017","unstructured":"Arbustini E, Favalli V, Narula N. LMNA Mutations associated with mild and late-onset phenotype: the case of the Dutch founder mutation p. (Arg331Gln). Circ Cardiovasc Genet. 2017;10:10\u20133. https:\/\/doi.org\/10.1161\/CIRCGENETICS.117.001816.","journal-title":"Circ Cardiovasc Genet"},{"key":"2195_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cardfail.2013.03.001","volume":"19","author":"C Brodt","year":"2013","unstructured":"Brodt C, Siegfried JD, Hofmeyer M, et al. Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy. J Card Fail. 2013;19:233\u20139. https:\/\/doi.org\/10.1016\/j.cardfail.2013.03.001.","journal-title":"J Card Fail"},{"key":"2195_CR35","doi-asserted-by":"publisher","first-page":"7689","DOI":"10.1073\/pnas.1707741114","volume":"114","author":"K Ito","year":"2017","unstructured":"Ito K, Patel PN, Gorham JM, et al. Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing. Proc Natl Acad Sci U S A. 2017;114:7689\u201394. https:\/\/doi.org\/10.1073\/pnas.1707741114.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2195_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00392-016-1033-6","volume":"106","author":"E Kayvanpour","year":"2017","unstructured":"Kayvanpour E, Sedaghat-Hamedani F, Amr A, et al. Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals. Clin Res Cardiol. 2017;106:127\u201339. https:\/\/doi.org\/10.1007\/s00392-016-1033-6.","journal-title":"Clin Res Cardiol"},{"key":"2195_CR37","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ejheart.2005.11.004","volume":"8","author":"A Perrot","year":"2006","unstructured":"Perrot A, Sigusch HH, N\u00e4gele H, et al. Genetic and phenotypic analysis of dilated cardiomyopathy with conduction system disease: demand for strategies in the management of presymptomatic lamin A\/C mutant carriers. Eur J Heart Fail. 2006;8:484\u201393. https:\/\/doi.org\/10.1016\/j.ejheart.2005.11.004.","journal-title":"Eur J Heart Fail"},{"key":"2195_CR38","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/eurheartj\/ehx596","volume":"39","author":"NE Hasselberg","year":"2018","unstructured":"Hasselberg NE, Haland TF, Saberniak J, et al. Lamin A\/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation. Eur Heart J. 2018;39:853\u201360. https:\/\/doi.org\/10.1093\/eurheartj\/ehx596.","journal-title":"Eur Heart J"},{"key":"2195_CR39","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","volume":"68","author":"S Kumar","year":"2016","unstructured":"Kumar S, Baldinger SH, Gandjbakhch E, et al. Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers. J Am Coll Cardiol. 2016;68:2299\u2013307. https:\/\/doi.org\/10.1016\/j.jacc.2016.08.058.","journal-title":"J Am Coll Cardiol"},{"key":"2195_CR40","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","volume":"52","author":"M Pasotti","year":"2008","unstructured":"Pasotti M, Klersy C, Pilotto A, et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol. 2008;52:1250\u201360. https:\/\/doi.org\/10.1016\/j.jacc.2008.06.044.","journal-title":"J Am Coll Cardiol"},{"key":"2195_CR41","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/europace\/eut291","volume":"16","author":"NE Hasselberg","year":"2014","unstructured":"Hasselberg NE, Edvardsen T, Petri H, et al. Risk prediction of ventricular arrhythmias and myocardial function in Lamin A\/C mutation positive subjects. Europace. 2014;16:563\u201371. https:\/\/doi.org\/10.1093\/europace\/eut291.","journal-title":"Europace"},{"key":"2195_CR42","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.hrthm.2023.03.1538","volume":"20","author":"MK Chung","year":"2023","unstructured":"Chung MK, Patton KK, Lau CP, et al. 2023 HRS\/APHRS\/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. Hear Rhythm. 2023;20:e17\u201391. https:\/\/doi.org\/10.1016\/j.hrthm.2023.03.1538.","journal-title":"Hear Rhythm"},{"issue":"2","key":"2195_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMc052632","volume":"354","author":"C Meune","year":"2006","unstructured":"Meune C, Van Berlo JH, Anselme F, et al. Primary prevention of sudden death in patients with lamin A\/C gene mutations. Nejm. 2006;354(2):209\u201310.","journal-title":"Nejm"},{"key":"2195_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/openhrt-2021-001622","volume":"8","author":"LH Ollila","year":"2021","unstructured":"Ollila LH, Nikus K, Parikka H, et al. Timing of pacemaker and ICD implantation in LMNA mutation carriers. Open Hear. 2021;8:1\u20137. https:\/\/doi.org\/10.1136\/openhrt-2021-001622.","journal-title":"Open Hear"},{"key":"2195_CR45","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1253\/circj.CJ-18-0339","volume":"82","author":"K Nakajima","year":"2018","unstructured":"Nakajima K, Aiba T, Makiyama T, et al. Clinical manifestations and long-term mortality in lamin A\/C mutation carriers from a Japanese multicenter registry. Circ J. 2018;82:2707\u201314. https:\/\/doi.org\/10.1253\/circj.CJ-18-0339.","journal-title":"Circ J"},{"key":"2195_CR46","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1161\/01.STR.0000064322.47667.49","volume":"34","author":"G Boriani","year":"2003","unstructured":"Boriani G, Gallina M, Merlini L, et al. Clinical relevance of atrial fibrillation\/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study. Stroke. 2003;34:901\u20138. https:\/\/doi.org\/10.1161\/01.STR.0000064322.47667.49.","journal-title":"Stroke"},{"key":"2195_CR47","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/europace\/euv098","volume":"18","author":"B Bellmann","year":"2016","unstructured":"Bellmann B, Roser M, Muntean B, et al. Atrial standstill in sinus node disease due to extensive atrial fibrosis: impact on dual chamber pacemaker implantation. Europace. 2016;18:238\u201345. https:\/\/doi.org\/10.1093\/europace\/euv098.","journal-title":"Europace"},{"key":"2195_CR48","doi-asserted-by":"publisher","unstructured":"Zhang Y, Zhang Y, Ren M, et al. Atrial standstill associated with lamin A\/C mutation: a case report. SAGE Open Med Case Rep. 2023;11. https:\/\/doi.org\/10.1177\/2050313X231179810.","DOI":"10.1177\/2050313X231179810"},{"key":"2195_CR49","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ijcard.2012.09.118","volume":"168","author":"IAW Van Rijsingen","year":"2013","unstructured":"Van Rijsingen IAW, Bakker A, Azim D, et al. Lamin A\/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications. Int J Cardiol. 2013;168:472\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2012.09.118.","journal-title":"Int J Cardiol"},{"key":"2195_CR50","doi-asserted-by":"publisher","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS): developed by the task force for the management of atrial fibrillation of the european society of cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. endorsed by the european stroke organisation (ESO). Eur Heart J. 2024;1\u2013101. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176.","DOI":"10.1093\/eurheartj\/ehae176"},{"key":"2195_CR51","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1056\/nejmoa1302946","volume":"368","author":"DH Birnie","year":"2013","unstructured":"Birnie DH, Healey JS, Wells GA, et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med. 2013;368:2084\u201393. https:\/\/doi.org\/10.1056\/nejmoa1302946.","journal-title":"N Engl J Med"},{"key":"2195_CR52","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79:e263\u2013421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012.","journal-title":"J Am Coll Cardiol"},{"key":"2195_CR53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ejhf.3024","volume":"26","author":"TA McDonagh","year":"2024","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) W. Eur J Heart Fail. 2024;26:5\u201317. https:\/\/doi.org\/10.1002\/ejhf.3024.","journal-title":"Eur J Heart Fail"},{"key":"2195_CR54","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/CIRCRESAHA.109.204388","volume":"106","author":"S Chandar","year":"2010","unstructured":"Chandar S, Yeo LS, Leimena C, et al. Effects of mechanical stress and carvedilol in lamin A\/C-deficient dilated cardiomyopathy. Circ Res. 2010;106:573\u201382. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.204388.","journal-title":"Circ Res"},{"key":"2195_CR55","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bbrc.2014.09.020","volume":"452","author":"A Muchir","year":"2014","unstructured":"Muchir A, Wu W, Sera F, et al. Mitogen-activated protein kinase kinase 1\/2 inhibition and angiotensin II converting inhibition in mice with cardiomyopathy caused by lamin A\/C gene mutation. Biochem Biophys Res Commun. 2014;452:958\u201361. https:\/\/doi.org\/10.1016\/j.bbrc.2014.09.020.","journal-title":"Biochem Biophys Res Commun"},{"key":"2195_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-20114-9","volume":"8","author":"T Tobita","year":"2018","unstructured":"Tobita T, Nomura S, Fujita T, et al. Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. Sci Rep. 2018;8:1\u201311. https:\/\/doi.org\/10.1038\/s41598-018-20114-9.","journal-title":"Sci Rep"},{"key":"2195_CR57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10741-020-09991-3","volume":"27","author":"AL Vecchi","year":"2022","unstructured":"Vecchi AL, Abete R, Marazzato J, et al. Ventricular arrhythmias and ARNI: is it time to reappraise their management in the light of new evidence? Heart Fail Rev. 2022;27:103\u201310. https:\/\/doi.org\/10.1007\/s10741-020-09991-3.","journal-title":"Heart Fail Rev"},{"key":"2195_CR58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jacbts.2022.05.010","volume":"8","author":"B Bozkurt","year":"2023","unstructured":"Bozkurt B, Nair AP, Misra A, et al. Neprilysin inhibitors in heart failure: the science, mechanism of action, clinical studies, and unanswered questions. JACC Basic Transl Sci. 2023;8:88\u2013105. https:\/\/doi.org\/10.1016\/j.jacbts.2022.05.010.","journal-title":"JACC Basic Transl Sci"},{"key":"2195_CR59","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.122.061732","volume":"146","author":"M Packer","year":"2022","unstructured":"Packer M. Critical reanalysis of the mechanisms underlying the cardiorenal benefits of SGLT2 inhibitors and reaffirmation of the nutrient deprivation signaling\/autophagy hypothesis. Circulation. 2022;146:1383\u2013405. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.061732.","journal-title":"Circulation"},{"key":"2195_CR60","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/ejhf.2463","volume":"24","author":"K Sidhu","year":"2022","unstructured":"Sidhu K, Castrini AI, Parikh V, et al. The response to cardiac resynchronization therapy in LMNA cardiomyopathy. Eur J Heart Fail. 2022;24:685\u201393. https:\/\/doi.org\/10.1002\/ejhf.2463.","journal-title":"Eur J Heart Fail"},{"key":"2195_CR61","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.cardfail.2023.01.011","volume":"29","author":"T Yamada","year":"2023","unstructured":"Yamada T, Nomura S, Amiya E, et al. LMNA mutations and right heart failure in patients with cardiomyopathy and with left ventricular assist devices. J Card Fail. 2023;29:855\u20137. https:\/\/doi.org\/10.1016\/j.cardfail.2023.01.011.","journal-title":"J Card Fail"},{"key":"2195_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells5030033","volume":"5","author":"L Maggi","year":"2016","unstructured":"Maggi L, Carboni N, Bernasconi P. Skeletal muscle laminopathies: a review of clinical and molecular features. Cells. 2016;5:1\u201314. https:\/\/doi.org\/10.3390\/cells5030033.","journal-title":"Cells"},{"key":"2195_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14955","author":"P Garcia-Pavia","year":"2024","unstructured":"Garcia-Pavia P, Lakdawala NK, Sinagra G, et al. Characterization and natural history of patients with LMNA-related dilated cardiomyopathy in the phase 3 REALM-DCM trial. ESC Hear Fail. 2024. https:\/\/doi.org\/10.1002\/ehf2.14955.","journal-title":"ESC Hear Fail"},{"key":"2195_CR64","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.hrthm.2024.01.027","volume":"21","author":"SC Vlay","year":"2024","unstructured":"Vlay SC. Thirty-five\u2013year follow-up of 3 generations of a family with LMNA cardiomyopathy. Hear Rhythm. 2024;21:696\u20137. https:\/\/doi.org\/10.1016\/j.hrthm.2024.01.027.","journal-title":"Hear Rhythm"},{"key":"2195_CR65","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijcard.2007.01.072","volume":"126","author":"X Fern\u00e1ndez","year":"2008","unstructured":"Fern\u00e1ndez X, Dumont CA, Monserrat L, et al. Sudden death in a patient with lamin A\/C gene mutation and near normal left ventricular systolic function. Int J Cardiol. 2008;126:136\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2007.01.072.","journal-title":"Int J Cardiol"},{"key":"2195_CR66","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.jacc.2017.10.053","volume":"72","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice gui. J Am Coll Cardiol. 2018;72:1677\u2013749. https:\/\/doi.org\/10.1016\/j.jacc.2017.10.053.","journal-title":"J Am Coll Cardiol"},{"key":"2195_CR67","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.jacc.2021.08.039","volume":"78","author":"L Escobar-Lopez","year":"2021","unstructured":"Escobar-Lopez L, Ochoa JP, Mirelis JG, et al. Association of genetic variants with outcomes in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2021;78:1682\u201399. https:\/\/doi.org\/10.1016\/j.jacc.2021.08.039.","journal-title":"J Am Coll Cardiol"},{"key":"2195_CR68","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/ehjci\/jead184","volume":"25","author":"F de Frutos","year":"2024","unstructured":"de Frutos F, Ochoa JP, Fern\u00e1ndez AI, et al. Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype\u2013phenotype correlation. Eur Heart J Cardiovasc Imaging. 2024;25:75\u201385. https:\/\/doi.org\/10.1093\/ehjci\/jead184.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2195_CR69","doi-asserted-by":"publisher","unstructured":"Fong KY, Ng CJR, Wang Y, et al. Subcutaneous versus transvenous implantable defibrillator therapy: a systematic review and meta-analysis of randomized trials and propensity score-matched studies. J Am Heart Assoc. 2022;11. https:\/\/doi.org\/10.1161\/JAHA.121.024756.","DOI":"10.1161\/JAHA.121.024756"},{"key":"2195_CR70","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.hrthm.2020.05.023","volume":"17","author":"K Sidhu","year":"2020","unstructured":"Sidhu K, Han L, Picard KCI, et al. Ventricular tachycardia in cardiolaminopathy: characteristics and considerations for device programming. Hear Rhythm. 2020;17:1704\u201310. https:\/\/doi.org\/10.1016\/j.hrthm.2020.05.023.","journal-title":"Hear Rhythm"},{"key":"2195_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCEP.116.004357","volume":"9","author":"S Kumar","year":"2016","unstructured":"Kumar S, Androulakis AFA, Sellal JM, et al. Multicenter experience with catheter ablation for ventricular tachycardia in lamin A\/C cardiomyopathy. Circ Arrhythmia Electrophysiol. 2016;9:1\u201311. https:\/\/doi.org\/10.1161\/CIRCEP.116.004357.","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"2195_CR72","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1161\/01.CIR.101.5.473","volume":"101","author":"GL Brodsky","year":"2000","unstructured":"Brodsky GL, Muntoni F, Miocic S, et al. Lamin A\/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation. 2000;101:473\u20136. https:\/\/doi.org\/10.1161\/01.CIR.101.5.473.","journal-title":"Circulation"},{"key":"2195_CR73","doi-asserted-by":"publisher","unstructured":"Maggi L. LMNA-associated myopathies: the Italian experience in a large cohort of patients. Orphanet J Rare Dis. 2015;10. https:\/\/doi.org\/10.1186\/1750-1172-10-s2-o19.","DOI":"10.1186\/1750-1172-10-s2-o19"},{"key":"2195_CR74","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1038\/s41436-019-0582-2","volume":"21","author":"M Catchpool","year":"2019","unstructured":"Catchpool M, Ramchand J, Martyn M, et al. A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy. Genet Med. 2019;21:2815\u201322. https:\/\/doi.org\/10.1038\/s41436-019-0582-2.","journal-title":"Genet Med"},{"key":"2195_CR75","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jacc.2019.05.022","volume":"74","author":"ES DeWitt","year":"2019","unstructured":"DeWitt ES, Chandler SF, Hylind RJ, et al. Phenotypic manifestations of arrhythmogenic cardiomyopathy in children and adolescents. J Am Coll Cardiol. 2019;74:346\u201358. https:\/\/doi.org\/10.1016\/j.jacc.2019.05.022.","journal-title":"J Am Coll Cardiol"},{"key":"2195_CR76","doi-asserted-by":"publisher","first-page":"E004416","DOI":"10.1161\/CIRCGEN.123.004416","volume":"17","author":"JAJ Verdonschot","year":"2024","unstructured":"Verdonschot JAJ, Hellebrekers DMEI, Van Empel VPM, et al. Clinical guideline for preimplantation genetic testing in inherited cardiac diseases. Circ Genomic Precis Med. 2024;17:E004416. https:\/\/doi.org\/10.1161\/CIRCGEN.123.004416.","journal-title":"Circ Genomic Precis Med"},{"key":"2195_CR77","doi-asserted-by":"publisher","first-page":"A13927","DOI":"10.1161\/circ.146.suppl_1.13927","volume":"146","author":"H Werner","year":"2022","unstructured":"Werner H, Gan ES, Loh CY, et al. Abstract 13927: AAV gene therapy to treat underlying cardiac biomechanical defects in lmna dilated cardiomyopathy improves lifespan and preserves ejection fraction in Lmna DCM mouse model. Circulation. 2022;146:A13927\u2013A13927. https:\/\/doi.org\/10.1161\/circ.146.suppl_1.13927.","journal-title":"Circulation"},{"key":"2195_CR78","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1093\/hmg\/dds265","volume":"21","author":"A Muchir","year":"2012","unstructured":"Muchir A, Wu W, Choi JC, et al. Abnormal p38\u03b1 mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A\/C gene mutation. Hum Mol Genet. 2012;21:4325\u201333. https:\/\/doi.org\/10.1093\/hmg\/dds265.","journal-title":"Hum Mol Genet"},{"key":"2195_CR79","doi-asserted-by":"publisher","first-page":"E003730","DOI":"10.1161\/CIRCGEN.122.003730","volume":"16","author":"CA Macrae","year":"2023","unstructured":"Macrae CA, Taylor MRG, Mestroni L, et al. Efficacy and safety of ARRY-371797 in LMNA-related dilated cardiomyopathy: a phase 2 study. Circ Genomic Precis Med. 2023;16:E003730. https:\/\/doi.org\/10.1161\/CIRCGEN.122.003730.","journal-title":"Circ Genomic Precis Med"},{"key":"2195_CR80","doi-asserted-by":"publisher","unstructured":"Garcia-Pavia P, Palomares JFR, Sinagra G, et al. REALM-DCM: a phase 3, multinational, randomized, placebo-controlled trial of ARRY-371797 in patients with symptomatic LMNA -related dilated cardiomyopathy. Circ Hear Fail. 2024;643\u2013655. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.123.011548.","DOI":"10.1161\/CIRCHEARTFAILURE.123.011548"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-025-02195-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-025-02195-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-025-02195-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:55:41Z","timestamp":1772096141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-025-02195-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2195"],"URL":"https:\/\/doi.org\/10.1007\/s11886-025-02195-x","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"7 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"No animal or human subjects by the authors were used in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"40"}}